These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10479278)

  • 1. Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents.
    Knutsen LJ; Andersen KE; Lau J; Lundt BF; Henry RF; Morton HE; Naerum L; Petersen H; Stephensen H; Suzdak PD; Swedberg MD; Thomsen C; Sørensen PO
    J Med Chem; 1999 Sep; 42(18):3447-62. PubMed ID: 10479278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.
    Borden LA; Murali Dhar TG; Smith KE; Weinshank RL; Branchek TA; Gluchowski C
    Eur J Pharmacol; 1994 Oct; 269(2):219-24. PubMed ID: 7851497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate.
    Andersen KE; Braestrup C; Grønwald FC; Jørgensen AS; Nielsen EB; Sonnewald U; Sørensen PO; Suzdak PD; Knutsen LJ
    J Med Chem; 1993 Jun; 36(12):1716-25. PubMed ID: 8510100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates.
    Andersen KE; Sørensen JL; Huusfeldt PO; Knutsen LJ; Lau J; Lundt BF; Petersen H; Suzdak PD; Swedberg MD
    J Med Chem; 1999 Oct; 42(21):4281-91. PubMed ID: 10543872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N-Omega asymmetrically substituted nipecotic acid derivatives.
    Andersen KE; Lau J; Lundt BF; Petersen H; Huusfeldt PO; Suzdak PD; Swedberg MD
    Bioorg Med Chem; 2001 Nov; 9(11):2773-85. PubMed ID: 11597457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of substituted triarylnipecotic acid derivatives as GABA uptake inhibitors: identification of a ligand with moderate affinity and selectivity for the cloned human GABA transporter GAT-3.
    Dhar TG; Borden LA; Tyagarajan S; Smith KE; Branchek TA; Weinshank RL; Gluchowski C
    J Med Chem; 1994 Jul; 37(15):2334-42. PubMed ID: 8057281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.
    White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
    J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel gamma-aminobutyric acid (GABA) uptake inhibitors. 5.(1) Preparation and structure-activity studies of tricyclic analogues of known GABA uptake inhibitors.
    Andersen KE; Sørensen JL; Lau J; Lundt BF; Petersen H; Huusfeldt PO; Suzdak PD; Swedberg MD
    J Med Chem; 2001 Jun; 44(13):2152-63. PubMed ID: 11405652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1.
    Dalby NO; Thomsen C; Fink-Jensen A; Lundbeck J; Søkilde B; Man CM; Sørensen PO; Meldrum B
    Epilepsy Res; 1997 Jul; 28(1):51-61. PubMed ID: 9255599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier.
    Braestrup C; Nielsen EB; Sonnewald U; Knutsen LJ; Andersen KE; Jansen JA; Frederiksen K; Andersen PH; Mortensen A; Suzdak PD
    J Neurochem; 1990 Feb; 54(2):639-47. PubMed ID: 2299358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro.
    Sabau A; Frahm C; Pfeiffer M; Breustedt J; Piechotta A; Numberger M; Engel D; Heinemann U; Draguhn A
    Eur J Pharmacol; 1999 Nov; 383(3):259-66. PubMed ID: 10594317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.
    Quandt G; Höfner G; Wanner KT
    Bioorg Med Chem; 2013 Jun; 21(11):3363-78. PubMed ID: 23598250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NNC-711, a novel potent and selective gamma-aminobutyric acid uptake inhibitor: pharmacological characterization.
    Suzdak PD; Frederiksen K; Andersen KE; Sørensen PO; Knutsen LJ; Nielsen EB
    Eur J Pharmacol; 1992 Dec; 224(2-3):189-98. PubMed ID: 1468507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy.
    Smith SE; Parvez NS; Chapman AG; Meldrum BS
    Eur J Pharmacol; 1995 Feb; 273(3):259-65. PubMed ID: 7737333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic mechanisms of gabitril (tiagabine) and future potential developments.
    Meldrum BS; Chapman AG
    Epilepsia; 1999; 40 Suppl 9():S2-6. PubMed ID: 10612355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of gamma-aminobutyric acid transport as experimental tools and therapeutic agents.
    Krogsgaard-Larsen P; Frølund BF; Falch E
    Methods Enzymol; 1998; 296():165-75. PubMed ID: 9779447
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs.
    Eckstein-Ludwig U; Fei J; Schwarz W
    Br J Pharmacol; 1999 Sep; 128(1):92-102. PubMed ID: 10498839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor.
    Nielsen EB; Suzdak PD; Andersen KE; Knutsen LJ; Sonnewald U; Braestrup C
    Eur J Pharmacol; 1991 Apr; 196(3):257-66. PubMed ID: 1832636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GABA transporter and its inhibitors.
    Soudijn W; van Wijngaarden I
    Curr Med Chem; 2000 Oct; 7(10):1063-79. PubMed ID: 10911018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity at the GABA transporter contributes to acute cellular swelling produced by metabolic impairment in retina.
    Zeevalk GD; Nicklas WJ
    Vision Res; 1997 Dec; 37(24):3463-70. PubMed ID: 9425523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.